参考文献/References:
［1］WIKSTRM SHEMER E, MARSCHALL H U, LUDVIGSSON J F, et al Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study ［J］. BJOG : an International Journal of Obstetrics and Gynaecology, 2013, 120(6): 717-723.
［2］BACQ Y, SENTILHES L, REYES H B, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis ［J］. Gastroenterology, 2012, 143(6): 1492-1501.
［3］Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid ［J］. Hepatology, 2005, 42(6):1399-1405.
［4］PUSL T, BEUERS U. Intrahepatic cholestasis of pregnancy［J］. Orphanet Journal of Rare Diseases, 2007, 2(1): 26.
［5］Rioseco AJ, Ivankovic MB, Manzur A, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome ［J］. Am J Obstet Gynecol, 1994,170(3):890-895.
［6］ZECCA E, DE LUCA D, MARRAS M, et al. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome ［J］. Pediatrics, 2006, 117(5): 1669-1672.
［7］Williamson C, Hems LM, Goulis DG, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group ［J］. BJOG,2004, 111(7):676.
［8］ZECCA E, DE LUCA D, BARONI S, et al. Bile acid-induced lung injury in newborn infants: a bronchoalveolar lavage fluid study ［J］. Pediatrics, 2008, 121(1): e146-e149.
［9］GEENES V, CHAPPELL L C, SEED P T, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study ［J］. Hepatology (Baltimore, Md.), 2014, 59(4): 1482-1491.
［10］Henderson CE, Shah RR, Gottimukkala S, et al. Primum non nocere: how active management became modus operandi for intrahepatic cholestasis of pregnancy ［J］. Am J Obstet Gynecol,2014,211(3):189-196.
［11］Williamson C, Miragoli M, Sheikh Abdul Kadir S, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy ［J］. Dig Dis, 2011,29(1): 58-61.
［12］GLANTZ A, MARSCHALL H U, MATTSSON L A. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates ［J］. Hepatology (Baltimore, Md.), 2004, 40(2): 467-474.
［13］OZTEKIN D, AYDAL I, OZTEKIN O, et al. Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy ［J］. Archives of Gynecology and Obstetrics, 2009, 280(6): 975-979.
［14］BROUWERS L, KOSTER M P, PAGE-CHRISTIAENS G C, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels ［J］. American Journal of Obstetrics and Gynecology, 2015, 212(1): 100.e1-100.e7.
［15］ROOK M, VARGAS J, CAUGHEY A, et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort ［J］. PLOS One, 2012, 7(3): e28343.
［16］Sentilhes L, Verspyck E, Pia P, et al. Fetal death in a patient with intrahepatic cholestasis of pregnancy ［J］. Obstet Gynecol, 2006, 107(2Pt2):458.
［17］LEE R H, INCERPI M H, MILLER D A, et al. Sudden fetal death in intrahepatic cholestasis of pregnancy ［J］. Obstetrics and Gynecology, 2009, 113(2 Pt 2): 528-531.
［18］Egerman RS, Riely CA. Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient? ［J］.Hepatology, 2004,40(2):287.
［19］Puljic A, Kim E, Page J, et al. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age ［J］. Am J Obstet Gynecol,2015, 212(5):667.e1.
［20］GEENES V. Intrahepatic cholestasis of pregnancy ［J］. World Journal of Gastroenterology, 2009, 15(17): 2049–2066.
［21］中华医学会妇产科学分会产科学组．妊娠期肝内胆汁淤积症诊疗指南(2011) ［J］．中华妇产科杂志，2011，46（5）：391-394．
［22］中华医学会妇产科学分会产科学组．妊娠期肝内胆汁淤积症诊疗指南(2015) ［J］．临床肝胆病杂志，2015，31（10）：1575-1578．
相似文献/References:
[1]侯卫萍.妊娠期肝内胆汁淤积症的围产儿结局探讨[J].中国计划生育和妇产科,2012,(03):0.
HOU Wei - Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(3):0.
[2]徐洲,王晓银,肖兵,等.妊娠期肝内胆汁淤积症分娩时机及方式探讨[J].中国计划生育和妇产科,2014,(04):0.
XU Zhou,WANG Xiao-yin,XIAO Bing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[3]李萍,陈红,赵虎,等.妊娠期肝内胆汁淤积症患者的分娩方式探讨[J].中国计划生育和妇产科,2014,(05):0.
LI Ping,CHEN Hong,ZHAO Hu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[4]潘玥*,李娥琼.不同孕周妊娠期肝内胆汁淤积症生化指标差异与围产儿预后的分析[J].中国计划生育和妇产科,2019,(1):53.
PAN Yue*,LI E-qiong.Analysis of biochemical markers of intrahepatic cholestasis of pregnancy in different gestational weeks and prognosis of perinatal infants[J].Chinese Journal of Family Planning & Gynecotokology,2019,(3):53.
[5]郑双云*,韦瑞红,陈凤英,等.妊娠期肝内胆汁淤积症行茵栀黄、熊去氧胆酸及腺苷蛋氨酸联合治疗的临床效果观察[J].中国计划生育和妇产科,2019,(4):41.
ZHENG Shuang-yun*,WEI Rui-hong,CHEN Feng-ying,et al.Clinical efficacy of the Yinzhihuang, ursodeoxycholic acid and adenosylmethionine mattel combination therapy in the treatment of intrahepatic cholestasis of pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2019,(3):41.
[6]肖俊,张宇骄,傅晓冬*.熊去氧胆酸联合茵陈制剂治疗妊娠期肝内胆汁淤积症的有效性及母婴结局的Meta分析[J].中国计划生育和妇产科,2019,(5):81.
XIAO Jun,ZHANG Yu-jiao,FU Xiao-dong*.A meta-analysis of the efficiency and the maternal and infant outcome by applying ursodeoxycholic acid associate with Yinchen decoction in treatment of intrahepatic cholestasis of pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2019,(3):81.